4383 Medical Dr, San Antonio, TX 78229

128350244_403606127718797_17586983407868

Global Leaders in Advanced Cancer Research

Search Our Trials

START Research by

The Numbers

Square feet of world-class research facilities

Oncology Drugs Brought To Market

Full List of Drugs

Locations across the United States and Europe

Why Participate in a Clinical Trial?

With your participation in a clinical trial, we can develop new cancer treatments that will change how the world fights cancer

START Research Capabilities

Phase I Clinical Trials

Non Clinical Research

This is where we test cancer drugs in human beings for the first time. With 13,000 square feet of testing facilities, START is a global leader in phase I cancer research

START performs clinical research to find new candidates for potential anti-cancer compounds.

Your START Research Team

The Doctors on the START Research Team are dedicated to developing novel anti-cancer agents. With their expertise and dedication to this science, patients around the world will have new and more effective opportunities to treat their cancers.

Meet the Doctors

START Research Blog

START & Sarah Cannon Partner to Advance Therapies for Patients with Cancer

South Texas Research Accelerated Therapeutics (START) and Sarah Cannon Research Institute announced today a new collaboration

76 Write a comment

START’s Dr. Steven Kalter Weighs In On ASCO Conference

START Center oncologist Dr. Steven Kalter weighed in on some of the most important aspects of ASCO (American Society of Clinical Oncology)

23 Write a comment

Genetic Testing for Cancer Treatment

Genetic testing for cancer treatment is an invaluable resource for cancer care. It helps cancer care specialists at The START Center

20 Write a comment

Lowering Your Risk for Cervical Cancer

This year alone, an estimated 12,990 women will be diagnosed with cervical cancer. But by taking the right steps to protect yourself

18 Write a comment

Medical Breakthrough For Recurrent Melanoma Patients

Melanoma is the most serious form of skin cancer, with more than 75,000 people diagnosed each year. Imlygic®, a new oncolytic viral thera...

9 Write a comment

The START Center Selected for The Oncology Care Model Program

We’re excited and honored to announce that The START Center for Cancer Care has been selected for a unique and ambitious program

16 Write a comment